This invention relates to bicyclic tetrahydrothiazepine of formula (I), wherein in formula (I), R1 to R3, X1, X2, and R18 have the meanings as defined in the specification and claims. The invention further relates to pharmaceutical compositions comprising such compounds, as well as methods for treating or preventing neoplastic diseases and/or infectious diseases, and their use as medicaments in in vitro methods.